Asian consumers, boomerang businesses and M&A likely to shape 2021 January 6, 2021 It was some year. Anyone who took on the challenge of forecasting what would happen in 2020 more than likely saw it all swiftly swept aside – but, as they say, prediction is very difficult, especially when it’s about the future. Still, investing is a forward-looking profession and so we inevitably find ourselves thinking about [...]
How close are we to having an approved coronavirus vaccine? October 28, 2020 There are a number of vaccine programmes which have advanced to stage three trials, the final hurdle before approval, including two based in the UK. How are they progressing?
GSK profit falls a fifth in the third quarter October 28, 2020 Glaxosmithkline (GSK) saw profit attributable to shareholders slip nearly a fifth in the third quarter, but said it was on track to deliver on its guidance for the year. The update came after the pharma giant announced that it would provide a global coronavirus vaccine programme with 200m doses of its candidate. Over the three [...]
GSK and Sanofi begin human trials of coronavirus vaccine September 3, 2020 Glaxosmithkline (GSK) has today announced that it is beginning human trials of the coronavirus vaccine it is developing with French pharma firm Sanofi. The two joined forces back in April to develop the potential vaccine, testing of which is now ready to move to the next stage after promising initial results. The combined phase 1 [...]
GSK sales fall as vaccine demand slumps during lockdown July 29, 2020 Revenue at drugs giant Glaxosmithkline (GSK) fell below analyst expectations today as sales of its blockbuster Shingles vaccine contracted sharply in the second quarter. Turnover dropped three per cent to £7.6bn, a little below forecasts of £7.7bn, while earnings per share fell back to 19.2p, lower than the 20.1p predicted. Shares in the FTSE 100 [...]
GSK plans to make 1bn coronavirus vaccine booster shots May 28, 2020 Drug giant Glaxosmithkline (GSK) today announced that it would aim to produce 1bn vaccine booster shots next year in a bid to improve the efficacy of potential new coronavirus treatments. These booster shots, which are called adjuvants, are a key part of vaccine development as they help patients develop a longer lasting immunity to disease. [...]
GSK beats expectations with strong first quarter performance April 29, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) beat analysts’ expectations with its first quarter results today, and said it remained on course to fulfil its 2020 guidance. The performance, which the firm labelled “strong”, was founded on high demand for its shingles treatment shingrix and higher sales of pain medications during the coronavirus crisis. GSK shares were flat [...]
Coronavirus: GSK chief urges drug firms to work together to develop vaccines April 15, 2020 The chief executive of pharmaceuticals giant Glaxosmithkline (GSK) has urged companies to join together to speed the development of a coronavirus vaccine, warning that the world will need more than one treatment for the disease. Emma Walmsley’s words came after the firm announced it had partnered with French drugmaker Sanofi to make a vaccine. Clinical [...]
GSK partners with Sanofi to develop coronavirus vaccine April 14, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) has joined forces with French drugmaker Sanofi to develop a vaccine for the coronavirus disease. The two firms said that they were planning to begin clinical trials for the new treatment in the second half of this year. If successful, it is hoped that the vaccine would become available in the [...]
Pharma giant GSK takes $250m stake in firm to develop coronavirus vaccine April 7, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) has taken a $250m (£202.7m) stake in an American biotech company in a collaborative effort to make a vaccine for Covid-19. Vir Biotechnology, of which GSK now owns a 6 per cent stake, specialises in the treatment of severe infectious diseases, and is looking to develop an antibody treatment for the [...]